Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanopore Mechanism Allows Single Strand DNA Sequencing

By LabMedica International staff writers
Posted on 09 Apr 2012
A recent paper described dramatic progress in the development of a nanopore mechanism for rapid sequencing of single DNA strands.

The study, which was published in in the March 25, 2012, online edition of the journal Nature Biotechnology, was based on a nanopore structure that had been created by genetic engineering of a protein pore from Mycobacterium smegmatis. More...
The diameter of the pore was such that only a single strand of DNA could pass through. A molecule of DNA polymerase was attached to the nanopore and acted to pull the DNA strand through the pore. The nanopore structure was placed in a membrane surrounded by potassium-chloride solution, with a small voltage applied to create an ion current flowing through the nanopore.

Details presented in the study revealed that the electrical signature produced by the pore changed depending on the type of nucleotide traveling through it. Each type of DNA nucleotide - cytosine, guanine, adenine, and thymine – produced a distinctive signature. The nanopore complex was tested with six different strands of DNA, and results corresponded to the already known DNA sequence of the strands, which had readable regions 42 to 53 nucleotides long.

“There is a clear path to a workable, easily produced sequencing platform,” said senior author Dr. Jens Gundlach, professor of physics at the University of Washington (Seattle, USA). “We augmented a protein nanopore we developed for this purpose with a molecular motor that moves a DNA strand through the pore a nucleotide at a time. The motor pulls the strand through the pore at a manageable speed of tens of milliseconds per nucleotide, which is slow enough to be able to read the current signal.”

“Epigenetic modifications are rather important for things like cancer," said Dr. Gundlach. “Being able to provide DNA sequencing that can identify epigenetic changes is one of the charms of the nanopore sequencing method. With techniques like this, it might get down to a 10-dollar or 15-minute genome project. It is moving fast.”

Related Links:
University of Washington




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.